(Total Views: 349)
Posted On: 03/04/2021 12:42:25 PM
Post# of 148938
FDA needs a victory all they have been doing is approving loser failures.
Conv Plasma - study stopped no Benefit for Severe critical Covid-19 patients. Nothing available for severe critical to reduce mortality. The world will need a stock pile of leronlimab.
Leronlimab will be New supercharged improved SOC.
https://www.usatoday.com/story/news/health/20...901125002/
Conv Plasma - study stopped no Benefit for Severe critical Covid-19 patients. Nothing available for severe critical to reduce mortality. The world will need a stock pile of leronlimab.
Leronlimab will be New supercharged improved SOC.
https://www.usatoday.com/story/news/health/20...901125002/
(2)
(0)Scroll down for more posts ▼
